Loading…
This event has ended. View the official site or create your own event → Check it out
This event has ended. Create your own
View analytic
Tuesday, June 20 • 10:30am - 11:45am
#223: Introduction to Rare Disease Studies: Challenges of Rare Disease From a Statistical, Protocol Development, and Operations Perspective

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Session
Level: Intermediate
CE: CME 1.25; IACET 1.25; RN 1.25

This session is planned to provide a basic overview of studies in rare diseases and how they differ from most other therapeutic areas. Brief overview of the challenges will be presented with special emphasis on statistical challenges, protocol design realities, operational changes required and recruiting perspectives.

Learning Objectives

Identify a better understanding of the differences in special population studies and some possible solutions.

Chair

William B. Smith, MD

Speaker

FDA Perspective
Yeh-Fong Chen, PhD

Industry Perspective
Robert P. Homolka, MBA, MS

Panelist
Gil Price, MD



Moderators
avatar for William Smith

William Smith

President, New Orleans Center for Clinical Research
William B. Smith, MD, FACC, is a Professor of Medicine at the University of Tennessee Medical Center in Knoxville, Tennessee. Dr. Smith is board certified in Nephrology, Internal Medicine, Cardiology and Critical Care. Dr. Smith is the President of New Orleans Center for Clinical... Read More →

Speakers
avatar for Yeh-Fong Chen

Yeh-Fong Chen

Mathematical Statistician, Office of Translational Sciences, CDER, FDA
Dr. Yeh-Fong Chen is the statistical team leader supporting the Division of Gastroenterology and Inborn Errors Products at the Division of Biometrics III at US Food and Drug Association. She joined FDA in 2000 immediately after graduation with a PhD degree in Statistics from the... Read More →
RH

Robert Homolka

Clinical Pharmacology Group Lead, Shire
Mr. Robert Homolka is the Director of Clinical Pharmacology Operations at Shire. For the last 20 years, Mr. Homolka has worked at AstraZeneca followed by Shire in Clinical Pharmacology. He has participated in, managed, and/ or overseen more than 200 studies while part of Clinical... Read More →
avatar for Gil Price

Gil Price

Chief Medical Officer, Propharma Group
Over the past 25 years, Dr. Price has worked in various capacities including professional communications, clinical development, and pharmacovigilance in differing therapeutic areas including vaccines, oncology, and infectious disease. He is considered by many to be a KOL in pharm... Read More →
avatar for William Smith

William Smith

President, New Orleans Center for Clinical Research
William B. Smith, MD, FACC, is a Professor of Medicine at the University of Tennessee Medical Center in Knoxville, Tennessee. Dr. Smith is board certified in Nephrology, Internal Medicine, Cardiology and Critical Care. Dr. Smith is the President of New Orleans Center for Clinical... Read More →


Tuesday June 20, 2017 10:30am - 11:45am
S503ab McCormick Place 2301 South Martin Luther King Jr. Drive, Gate 4 Chicago, IL 60616